Paroxetine decreased plasma exposure of glyburide partly via inhibiting intestinal absorption in rats
- 1 June 2015
- journal article
- Published by Elsevier in Drug Metabolism and Pharmacokinetics
- Vol. 30 (3) , 240-246
Abstract
No abstract availableKeywords
Funding Information
- National Science Foundation of China (81373482, 81473273)
- Fundamental Research Funds for the Central Universities (2015PT042, ZD2014YX0026, PT2014YX0057)
This publication has 38 references indexed in Scilit:
- Steroid hormones specifically modify the activity of organic anion transporting polypeptidesEuropean Journal of Pharmaceutical Sciences, 2012
- Combined Contributions of Impaired Hepatic CYP2C11 and Intestinal Breast Cancer Resistance Protein Activities and Expression to Increased Oral Glibenclamide Exposure in Rats with Streptozotocin-Induced Diabetes MellitusDrug Metabolism and Disposition, 2012
- Identification of the major human hepatic and placental enzymes responsible for the biotransformation of glyburideBiochemical Pharmacology, 2009
- Breast Cancer Resistance Protein: Mediating the Trans-placental Transfer of Glyburide across the Human PlacentaPlacenta, 2008
- Naringin is a Major and Selective Clinical Inhibitor of Organic Anion-Transporting Polypeptide 1A2 (OATP1A2) in Grapefruit JuiceClinical Pharmacology & Therapeutics, 2007
- Intestinal Drug Transporter Expression and the Impact of Grapefruit Juice in HumansClinical Pharmacology & Therapeutics, 2007
- Selectivity of repaglinide and glibenclamide for the pancreatic over the cardiovascular KATP channelsDiabetologia, 2006
- Secondary sulfonylurea failure: Comparison of period until insulin treatment between diabetic patients treated with gliclazide and glibenclamideDiabetes Research and Clinical Practice, 2005
- , but not , polymorphisms affect the pharmacokinetics and pharmacodynamics of glyburide in Chinese subjectsClinical Pharmacology & Therapeutics, 2005
- Review of glyburide after one year on the marketThe American Journal of Medicine, 1985